FATE THERAPEUTICS INC — Director's Dealing 2014

Jan 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2014-01-09

Reporting Person: Multani Pratik S (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-09	Stock Option (right to buy)	$6.62	A	85000	Acquired	2024-01-08	Common Stock (85000)	Direct

Footnotes

F1: The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on November 4, 2013 such that this option is fully exercisable on October 4, 2017.

F2: Not applicable.